About
Welsh Carson Anderson & Stowe is a private equity firm founded in 1979 and based in New York City that specializes exclusively in healthcare and technology investments. The firm has established itself as a mega-sized specialist investor with a disciplined focus on growth-oriented companies in these two sectors over more than four decades of operation. WCAS pursues a broad range of transaction types including traditional buyouts, growth equity investments, buy-and-build acquisitions, public-to-private transactions, and corporate carve-outs, demonstrating flexibility across deal structures and company stages. The firm shows a preference for control situations and generally focuses its investment activity on opportunities within the United States. Since its founding, WCAS has deployed capital across more than 100 portfolio companies and currently manages approximately $31 billion in assets under management across multiple funds, with its most recent fund, WCAS XIV LP, closing with over $5 billion in capital commitments. This latest fund represents the firm's largest fund raise to date. The firm's investment approach emphasizes partnering with management teams to enhance operational performance and execute strategic acquisitions within portfolio companies. Recent deal activity includes the February 2024 acquisition of AssistRx for approximately $600 million, demonstrating continued active deployment of capital. As of 2026, the firm maintains an active portfolio of approximately 109 companies. The firm's longevity through multiple market cycles, spanning the dot-com era through present-day market conditions, provides institutional experience navigating diverse economic environments. WCAS serves as a resource for both portfolio company management teams seeking operational and strategic support and institutional limited partners seeking exposure to healthcare and technology sectors through a seasoned investment vehicle.